Author: Carrasco, ItzÃar; Muñoz-Chapuli, Mar; Vigil-Vázquez, Sara; Aguilera-Alonso, David; Hernández, Concepción; Sánchez-Sánchez, César; Oliver, Cristina; Riaza, Mónica; Pareja, Marta; Sanz, Olga; Pérez-Seoane, Beatriz; López, Juan; Márquez, Elena; DomÃnguez-RodrÃguez, Sara; Hernanz-Lobo, Alicia; De León-Luis, Juan Antonio; Sánchez-Luna, Manuel; Navarro, MarÃa Luisa
Title: SARS-COV-2 infection in pregnant women and newborns in a Spanish cohort (GESNEO-COVID) during the first wave Cord-id: mrrzce18 Document date: 2021_4_26
ID: mrrzce18
Snippet: BACKGROUND: Knowledge about SARS-CoV-2 infection in pregnancy and newborns is scarce. The objective of this study is to analyse clinical and epidemiological characteristics of a cohort of women infected with SARS-CoV-2 during pregnancy and their newborns exposed to SARS-CoV-2 during gestation. METHODS: Multicentric observational study of Spanish hospitals from the GESNEO-COVD cohort, participants in RECLIP (Spanish Network of Paediatric Clinical Assays). Women with confirmed SARS-CoV-2 infection
Document: BACKGROUND: Knowledge about SARS-CoV-2 infection in pregnancy and newborns is scarce. The objective of this study is to analyse clinical and epidemiological characteristics of a cohort of women infected with SARS-CoV-2 during pregnancy and their newborns exposed to SARS-CoV-2 during gestation. METHODS: Multicentric observational study of Spanish hospitals from the GESNEO-COVD cohort, participants in RECLIP (Spanish Network of Paediatric Clinical Assays). Women with confirmed SARS-CoV-2 infection by PCR and/or serology during pregnancy, diagnosed and delivering during the period 15/03/2020–31/07/2020 were included. Epidemiological, clinical, and analytical data was collected. RESULTS: A total of 105 pregnant women with a median of 34.1 years old (IQR: 28.8–37.1) and 107 newborns were included. Globally, almost 65% of pregnant women had some COVID-19 symptoms and more than 43% were treated for SARS-COV-2. Overall, 30.8% of pregnant women had pneumonia and 5 (4.8%) women were admitted to the intensive care unit needing invasive mechanical ventilation. There was a rate of 36.2% of caesarean sections, which was associated with pneumonia during pregnancy (OR: 4.203, CI 95%: 1.473–11.995) and lower gestational age at delivery (OR: 0.724, CI 95%: 0.578–0.906). The prevalence of preterm birth was 20.6% and prematurity was associated with pneumonia during gestation (OR: 6.970, CI95%: 2.340–22.750) and having a positive SARS-CoV-2 PCR at delivery (OR: 6.520, CI95%: 1.840–31.790). All nasopharyngeal PCR in newborns were negative at birth and one positivized at 15 days of life. Two newborns died, one due to causes related to prematurity and another of unexpected sudden death during early skin-to-skin contact after delivery. CONCLUSIONS: Although vertical transmission has not been reported in this cohort, the prognosis of newborns could be worsened by SARS-CoV-2 infection during pregnancy as COVID-19 pneumonia increased the risk of caesarean section deliveries and preterm births.
Search related documents:
Co phrase search for related documents- acceptable good and lung disease: 1
- active infection and additional research: 1
- active infection and lopinavir ritonavir: 1, 2
- active infection and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- active infection and lymphocyte low count: 1, 2
- additional research and long term effect: 1
- additional research and lopinavir ritonavir: 1, 2
- additional research and lung disease: 1, 2, 3, 4, 5
- admission previous and lopinavir ritonavir: 1, 2
- liver enzyme and lopinavir ritonavir: 1, 2, 3, 4
- liver enzyme and lung disease: 1
Co phrase search for related documents, hyperlinks ordered by date